Hydration for myoclonus

Abstract

Get full access to this article

View all access options for this article.

References

Marin PP , Bayer AJ , Tomlinson A , Pathy MS . Attitudes of hospital doctors in Wales to use of intravenous fluids and antibiotics in the terminally ill . Postgrad Med J 1989; 65: 650–652 .

Andrews MR , Levine AM . Dehydration in the terminal patient: perception of hospice nurses . Am J Hosp Care 1989; 6: 31–34 .

Bruera E , Belzile M , Watanabe S , Fainsinger RL . Volume of hydration in terminal cancer patients . Support Care Cancer 1996; 4: 147–150 .

Lanuke K , Fainsinger RL , DeMoissac D . Hydration management at the end of life . J Palliat Med 2004; 7: 257–263 .

Burge FI . Dehydration symptoms of palliative care cancer patients . J Pain Symptom Manage 1993; 8: 454–464 .

Ellershaw JE , Sutcliffe JM , Saunders CM . Dehydration and the dying patient . J Pain Symptom Manage 1995; 10: 192–197 .

Morita T , Tei Y , Tsunoda J , Inoue S , Chihara S . Determinants of the sensation of thirst in terminally ill cancer patients . Support Care Cancer 2001; 9: 177–186 .

Musgrave CF , Bartal N , Opstad J . The sensation of thirst in dying patients receiving i.v. hydration . J Palliat Care 1995; 11: 17–21 .

McCann RM , Hall WJ , Groth-Juncker A . Comfort care for terminally ill patients. The appropriate use of nutrition and hydration . JAMA 1994; 272: 1263–1266 .

10.

Waller A , Hershkowitz M , Adunsky A . The effect of intravenous fluid infusion on blood and urine parameters of hydration and on state of consciousness in terminal cancer patients . Am J Hospice Palliat Care 1994; 11: 22–27 .

11.

Cerchietti L , Navigante A , Sauri A , Palazzo F . Hypodermoclysis for control of dehydration in terminal-stage cancer . Inter J Palliat Nurs 2000; 6: 370–374 .

12.

Morita T , Tei Y , Tsunoda J , Inoue S , Chihara S . Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients . J Pain Symptom Manage 2001; 22: 997–1006 .

13.

Morita T , Tei Y , Inoue S . Agitated terminal delirium and association with partial opioid substitution and hydration . J Palliat Med 2003; 6: 557–563 .

14.

Chiu TY , Hu WY , Chuang RB , Chen CY . Nutrition and hydration for terminal cancer patients in Taiwan . Support Care Cancer 2002; 10: 630–636 .

15.

Andersen G , Christrup L , Sjogren P . Relationships among morphine metabolism, pain and side effects during long-term treatment: an update . J Pain Symptom Manage 2003; 25: 74–91 .

16.

McNicol E , Horowicz-Mehler N , Fisk RA , et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review . J Pain 2003; 4: 231–256 .

17.

Cherny N , Ripamonti C , Pereira J , et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report . J Clin Oncol 2001; 19: 2542–2554 .

18.

Hagen N , Swanson R . Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: treatment strategies . J Pain Symptom Manage 1997; 14: 51–58 .

19.

Potter JM , Reid DB , Shaw RJ , Hackett P , Hickman PE . Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs . BMJ 1989; 299: 150–153 .